Gilead Sciences Inc. (GILD)
111.78
0.62 (0.56%)
At close: Mar 28, 2025, 3:59 PM
111.47
-0.28%
After-hours: Mar 28, 2025, 07:58 PM EDT
Cell Therapy Products, Total Cell Therapy Product Sales Revenue
History
| Quarter | Value | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 970M | 10M | +1.04% |
| Mar 31, 2024 | 960M | 960M | n/a |
| Dec 31, 2023 | 0 | -973M | -100.00% |
| Sep 30, 2023 | 973M | 36M | +3.84% |
| Jun 30, 2023 | 937M | 41M | +4.58% |
| Mar 31, 2023 | 896M | 896M | n/a |
| Dec 31, 2022 | 0 | -796M | -100.00% |
| Sep 30, 2022 | 796M | 60M | +8.15% |
| Jun 30, 2022 | 736M | 188M | +34.31% |
| Mar 31, 2022 | 548M | 548M | n/a |
| Dec 31, 2021 | 0 | -444M | -100.00% |
| Sep 30, 2021 | 444M | 6M | +1.37% |
| Jun 30, 2021 | 438M | 87M | +24.79% |
| Mar 31, 2021 | 351M | -16.6B | -97.93% |
| Dec 31, 2020 | 16.95B | 16.93B | +130261.54% |
| Sep 30, 2020 | 13M | -15M | -53.57% |
| Jun 30, 2020 | 28M | 20M | +250.00% |
| Mar 31, 2020 | 8M | -2M | -20.00% |
| Dec 31, 2019 | 10M | 5M | +100.00% |
| Sep 30, 2019 | 5M | -10M | -66.67% |
| Jun 30, 2019 | 15M | -2M | -11.76% |
| Mar 31, 2019 | 17M | -11M | -39.29% |
| Dec 31, 2018 | 28M | 14M | +100.00% |
| Sep 30, 2018 | 14M | -5M | -26.32% |
| Jun 30, 2018 | 19M | n/a | n/a |